2 ML ondansetron 2 MG/ML Injection — RxCUI 1740467
RxNorm drug concept · Semantic clinical drug
RxCUI 1740467
Semantic clinical drug · SCD
● Current RxNorm concept 41 FDA products
45 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1740467
Official name2 ML ondansetron 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asondansetron 4 MG per 2 ML Injection; ondansetron 4 MG in 2 ML Injection
FDA products mapped41
Package NDCs mapped45
Reported Medicaid activity (SDUD)894,101 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ondansetron: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Not at all. Ondansetron is approved to prevent nausea and vomiting from cancer chemotherapy, radiation therapy to the abdomen or whole body, and surgery. So you might receive it be...
- What exactly is ondansetron used for — is it just for chemo patients?
- The regular tablet is swallowed like any other pill. The orally disintegrating tablet (ODT) is placed on your tongue and allowed to dissolve — don't chew or swallow it whole. For c...
- How do I take the tablet or the dissolving tablet correctly?
🕸️ Concept Web — How 2 ML ondansetron 2 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML ondansetron 2 MG/ML Injection
RxCUI 1740467 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ondansetron
26225IN
-
Ondansetron
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ondansetron Injection
1740463SCDF -
Ondansetron Injectable Product
1161031SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Ondansetron Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ondansetron 2 MG/ML
328448SCDC
-
Ondansetron 2 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ondansetron 2 MG/ML
SCDC · 328448 -
Ondansetron Injection
SCDF · 1740463 -
Ondansetron Injectable Product
SCDG · 1161031
📦 FDA Products & Package NDCs
41 products · 45 package NDCs
45 package NDCs map to RxCUI 1740467 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9890-01 | 20 mL in 1 VIAL, MULTI-DOSE (0143-9890-01) | Ondansetron | West-Ward Pharmaceuticals Corp | 2006-12-26 |
| 00143-9890-10 | 10 VIAL, MULTI-DOSE in 1 CARTON (0143-9890-10) / 20 mL in 1... | Ondansetron | West-Ward Pharmaceuticals Corp | 2006-12-26 |
| 00143-9891-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9891-25) / 2 mL in 1... | Ondansetron | West-Ward Pharmaceuticals Corp | 2006-12-26 |
| 00404-9930-02 | 1 VIAL, SINGLE-USE in 1 BAG (0404-9930-02) / 2 mL in 1 VIAL... | ONDANSETRON | Henry Schein, Inc. | 2022-01-13 |
| 00409-0009-25 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-0009-25) / 2 mL in 1 V... | Ondansetron | Hospira, Inc. | 2024-12-16 |
| 00409-2271-25 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-2271-25) / 2 mL in 1 V... | Ondansetron | Hospira, Inc. | 2025-12-01 |
| 00409-4755-03 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4755-03) / 2 mL in 1 V... | Ondansetron | Hospira, Inc. | 2008-10-16 |
| 00409-4759-01 | 1 VIAL, MULTI-DOSE in 1 CARTON (0409-4759-01) / 20 mL in 1... | Ondansetron | Hospira, Inc. | 2006-11-07 |
| 00641-6078-25 | 25 VIAL in 1 CARTON (0641-6078-25) / 2 mL in 1 VIAL (0641-6... | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 00641-6079-01 | 20 mL in 1 CARTON (0641-6079-01) | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 00641-6080-25 | 25 VIAL in 1 CARTON (0641-6080-25) / 2 mL in 1 VIAL (0641-6... | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 00641-6286-01 | 20 mL in 1 VIAL, MULTI-DOSE (0641-6286-01) | Ondansetron | Hikma Pharmaceuticals USA Inc. | 2006-12-26 |
| 23155-0547-41 | 10 VIAL in 1 CARTON (23155-547-41) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-06-15 |
| 23155-0547-42 | 25 VIAL in 1 CARTON (23155-547-42) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-06-15 |
| 23155-0548-41 | 10 VIAL in 1 CARTON (23155-548-41) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-11-09 |
| 23155-0548-42 | 25 VIAL in 1 CARTON (23155-548-42) / 2 mL in 1 VIAL (23155-... | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-11-09 |
| 23155-0549-31 | 1 VIAL in 1 CARTON (23155-549-31) / 20 mL in 1 VIAL | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2012-06-15 |
| 23155-0550-31 | 1 VIAL in 1 CARTON (23155-550-31) / 20 mL in 1 VIAL | ONDANSETRON | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2015-11-09 |
| 25021-0777-02 | 25 VIAL in 1 CARTON (25021-777-02) / 2 mL in 1 VIAL | ondansetron | Sagent Pharmaceuticals | 2012-08-30 |
| 36000-0012-25 | 25 VIAL, SINGLE-DOSE in 1 CARTON (36000-012-25) / 2 mL in 1... | ONDANSETRON HYDROCHLORIDE | Baxter Healthcare Corporation | 2013-03-13 |
| 50090-4935-00 | 25 VIAL, SINGLE-USE in 1 CARTON (50090-4935-0) / 2 mL in 1... | ONDANSETRON | A-S Medication Solutions | 2020-02-27 |
| 51662-1245-01 | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1245-1) | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 2018-09-23 |
| 51662-1245-03 | 25 POUCH in 1 CASE (51662-1245-3) / 1 VIAL in 1 POUCH (5166... | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 2018-09-23 |
| 51662-1366-01 | 2 mL in 1 VIAL (51662-1366-1) | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 2019-12-08 |
| 51662-1469-01 | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1469-1) | ONDANSETRON | HF Acquisition Co LLC, DBA HealthFirst | 2019-12-14 |
| 55150-0125-02 | 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-125-02) / 2 mL in 1... | Ondansetron | Eugia US LLC | 2012-12-21 |
| 55150-0126-20 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-126-20) / 20 mL in 1... | Ondansetron | Eugia US LLC | 2012-12-21 |
| 55154-2876-05 | 5 VIAL in 1 BAG (55154-2876-5) / 2 mL in 1 VIAL | Ondansetron | Cardinal Health 107, LLC | 2006-12-26 |
| 55154-2877-05 | 5 VIAL in 1 BAG (55154-2877-5) / 2 mL in 1 VIAL | Ondansetron | Cardinal Health 107, LLC | 2006-12-26 |
| 55154-4453-05 | 5 VIAL in 1 BAG (55154-4453-5) / 2 mL in 1 VIAL | ONDANSETRON HYDROCHLORIDE | Cardinal Health 107, LLC | 2013-03-13 |
| 55154-6976-05 | 5 VIAL, SINGLE-DOSE in 1 BAG (55154-6976-5) / 2 mL in 1 VIA... | Ondansetron | Cardinal Health 107, LLC | 2008-10-16 |
| 60505-6130-05 | 25 VIAL, SINGLE-USE in 1 CARTON (60505-6130-5) / 2 mL in 1... | ONDANSETRON | Apotex Corp. | 2016-05-26 |
| 63323-0373-02 | 25 VIAL in 1 TRAY (63323-373-02) / 2 mL in 1 VIAL (63323-37... | Ondansetron | Fresenius Kabi USA, LLC | 2009-11-18 |
| 63323-0374-20 | 1 VIAL in 1 BOX (63323-374-20) / 20 mL in 1 VIAL | Ondansetron | Fresenius Kabi USA, LLC | 2009-11-18 |
| 65219-0323-02 | 25 VIAL in 1 TRAY (65219-323-02) / 2 mL in 1 VIAL (65219-32... | Ondansetron | Fresenius Kabi USA, LLC | 2024-01-22 |
| 67184-0507-05 | 5 VIAL, SINGLE-USE in 1 CARTON (67184-0507-5) / 2 mL in 1 V... | ONDANSETRON | Qilu Pharmaceutical Co., Ltd. | 2014-09-08 |
| 68083-0113-01 | 5 VIAL in 1 CARTON (68083-113-01) / 2 mL in 1 VIAL | Ondansetron | Gland Pharma Limited | 2009-09-25 |
| 71872-7068-01 | 1 VIAL, SINGLE-USE in 1 BAG (71872-7068-1) / 2 mL in 1 VIAL... | ONDANSETRON | Medical Purchasing Solutions, LLC | 2018-03-05 |
| 71872-7140-01 | 1 VIAL in 1 BAG (71872-7140-1) / 2 mL in 1 VIAL | Ondansetron | Medical Purchasing Solutions, LLC | 2018-06-05 |
| 71872-7162-01 | 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7162-1) / 2 mL in 1 VIA... | Ondansetron | Medical Purchasing Solutions, LLC | 2019-04-23 |
| 72266-0123-25 | 25 VIAL in 1 CARTON (72266-123-25) / 2 mL in 1 VIAL (72266-... | Ondansetron | Fosun Pharma USA Inc. | 2019-04-02 |
| 72266-0124-01 | 1 VIAL in 1 CARTON (72266-124-01) / 20 mL in 1 VIAL | Ondansetron | Fosun Pharma USA Inc. | 2019-04-02 |
| 72572-0520-25 | 25 VIAL in 1 CARTON (72572-520-25) / 2 mL in 1 VIAL (72572-... | Ondansetron | Civica, Inc. | 2019-11-18 |
| 83270-0160-03 | 25 VIAL, SINGLE-DOSE in 1 CARTON (83270-160-03) / 2 mL in 1... | ondansetron hydrochloride | Onesource Specialty Pharma Limited | 2023-09-30 |
| 84549-0130-05 | 2 mL in 1 VIAL, SINGLE-USE (84549-130-05) | ONDANSETRON | ProPharma Distribution | 2025-09-01 |
Observed labelers:
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (6) ·
Cardinal Health 107, LLC (4) ·
HF Acquisition Co LLC, DBA HealthFirst (4) ·
Hikma Pharmaceuticals USA Inc. (4) ·
Hospira, Inc. (4) ·
Fresenius Kabi USA, LLC (3)
· +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2405 | Ondansetron hcl injection | 24 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.